Crossmark Global Holdings, Inc. Simulations Plus, Inc. Transaction History

Crossmark Global Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 10, 2022	SELL	$37.1 - $57.45 $350,224 - $542,328	-9,440 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$38.45 - $55.66 $362,968 - $525,430	9,440 New	9,440 $373,000
Q3 2021 Oct 13, 2021	SELL	$38.45 - $55.66 $363,737 - $526,543	-9,460 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$49.67 - $68.96 $8,940 - $12,412	-180 Reduced 1.87%	9,460 $519,000
Q1 2021 Apr 15, 2021	SELL	$60.06 - $89.52 $6,006 - $8,952	-100 Reduced 1.03%	9,640 $610,000
Q4 2020 Jan 14, 2021	BUY	$53.26 - $77.18 $162,975 - $236,170	3,060 Added 45.81%	9,740 $701,000
Q3 2020 Oct 08, 2020	BUY	$57.51 - $75.36 $17,253 - $22,608	300 Added 4.7%	6,680 $503,000
Q2 2020 Aug 14, 2020	BUY	$32.91 - $59.82 $209,965 - $381,651	6,380 New	6,380 $382,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $574M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.